Literature DB >> 15831144

A rare case of Actinomyces israelii presenting as pericarditis in a 75-year-old man.

Amgad N Makaryus1, Joshua Latzman, Rayson Yang, David Rosman.   

Abstract

Actinomyces israelii is a gram-positive bacillus that is rarely associated with infections in the general population. A. israelii belongs to the normal flora of the body and it rarely becomes pathogenic. Cardiac involvement is rare and in most cases involves the pericardium. Fewer than 20 cases of pericardial actinomycosis have been reported in the literature since 1950. We report the case of a 75-year-old man with a history of coronary artery disease with recent myocardial infarction and stent placement, atrial fibrillation, and recent colonic perforation with subsequent colectomy/colostomy who presented to our hospital with a 2-week history of left-sided chest pain. Workup revealed the presence of a pericardial effusion and pericarditis. Pericardial fluid analysis demonstrated A. israelii. An examination and discussion of the literature is performed regarding this rare manifestation of human actinomycosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831144     DOI: 10.1097/01.crd.0000148846.97618.aa

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  3 in total

1.  Primary hepatic actinomycosis presenting as purulent pericarditis with cardiac tamponade.

Authors:  J Llenas-García; A Lalueza-Blanco; M Fernández-Ruiz; J Villar-Silva; M Ochoa; F Lozano; M Lizasoain; J M Aguado
Journal:  Infection       Date:  2011-10-15       Impact factor: 3.553

Review 2.  Actinomyces and related organisms in human infections.

Authors:  Eija Könönen; William G Wade
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

3.  A rare case of a cardiac papillary fibroelastoma of the pulmonary valve diagnosed by echocardiography.

Authors:  Matthew J Costa; Amgad N Makaryus; David R Rosman
Journal:  Int J Cardiovasc Imaging       Date:  2005-08-03       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.